Ginsenoside compound K induces mitochondrial apoptosis in human hepatoma cells through Bclaf1-mediated modulation of ERK signaling

Mitochondria Related Cell Death Modalities and Disease

(2022) Chuwen Tian et al.   Frontiers in Cell and Developmental Biology

Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook

(2022) Yinjie Fan et al.   Journal of Hepatocellular Carcinoma

Mitochondrial Mechanisms of Apoptosis and Necroptosis in Liver Diseases

(2021) Qingfei Chu et al.   Analytical Cellular Pathology

Function of BCLAF1 in human disease (Review)

(2021) Zongdong Yu et al.   Oncology Letters

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma

(2021) Danyu Du et al.   Acta Pharmaceutica Sinica B

Apoptosis – Fueling the oncogenic fire

(2020) Camila Castillo Ferrer et al.   FEBS Journal

Ginsenoside Compound K Regulates HIF-1α-Mediated Glycolysis Through Bclaf1 to Inhibit the Proliferation of Human Liver Cancer Cells

(2020) Silin Zhang et al.   Frontiers in Pharmacology

ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer

(2019) Iris C. Salaroglio et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Compound K Induces Endoplasmic Reticulum Stress and Apoptosis in Human Liver Cancer Cells by Regulating STAT3

(2018) Xuan Zhang et al.   MOLECULES

Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression

(2018) Silvia Márquez-Jurado et al.   Nature Communications

Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma

(2018) Ying Wen et al.   ONCOGENE

Connecting mitochondrial dynamics and life-or-death events via Bcl-2 family proteins

(2017) Abdel Aouacheria et al.   NEUROCHEMISTRY INTERNATIONAL